Eden vs MEDVi

Both sell tirzepatide. Eden costs $298 a month and MEDVi costs $399, a difference of $101 a month or about $1,212 a year. The desk reads it as follows.

Eden is low advertised medication price. MEDVi is tablet and injection choice. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. Eden advertises $199 and bills $298; MEDVi advertises $399 and bills $399. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

They differ on 2 of the 7 things we track, and behave the same on the other 5. The differences are what the price gap is actually buying.

What each puts on the record: Eden

• Compounded semaglutide advertised at $99/month.
• Compounded tirzepatide advertised at $199/month.
• Membership is $39 as an introductory rate, then $99/month ongoing.
• True ongoing cost for tirzepatide lands near $298/month once membership is included.

Where it wins: Genuinely low medication-only pricing. Watch for: The $99 semaglutide headline becomes roughly $198/month once the membership renews at its ongoing rate.

What each puts on the record: MEDVi

• Compounded tirzepatide injections listed at $399/month.
• Tirzepatide tablet pricing is quoted after the intake questionnaire rather than published up front.

Where it wins: Injection pricing is consistent between the first month and renewals. Watch for: You have to complete intake before seeing tablet pricing. Injection pricing is published at $399.

In each one’s favour

Eden.

• Genuinely low medication-only pricing.
• Fast onboarding with flat rates across published dose ranges.

MEDVi.

• Injection pricing is consistent between the first month and renewals.
• Tablet option for people who will not inject.

How they score

Eden scores higher overall at 3.1 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

The desk’s call

• Pick Eden if cost is the binding constraint. Over a year the gap is about $1,212, which is real money for the same class of medication.
• Pick MEDVi if what it does better matters to you — injection pricing is consistent between the first month and renewals.
• Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.

The verdict

On the board, Eden at $298 a month is the more defensible choice on arithmetic alone. MEDVi earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Eden and MEDVi.

How they sit against everyone else